» Articles » PMID: 38736612

A Vascularized Melanoma Model Suitable for Metastasis Research of Different Tumor Stages Using Fundamentally Different Bioinks

Abstract

Although 2D cancer models have been the standard for drug development, they don't resemble properties adequately. 3D models can potentially overcome this. Bioprinting is a promising technique for more refined models to investigate central processes in tumor development such as proliferation, dormancy or metastasis. We aimed to analyze bioinks, which could mimic these different tumor stages in a cast vascularized arteriovenous loop melanoma model . It has the advantage to be a closed system with a defined microenvironment, supplied only with one vessel-ideal for metastasis research. Tested bioinks showed significant differences in composition, printability, stiffness and microscopic pore structure, which led to different tumor stages (Matrigel and Alg/HA/Gel for progression, Cellink Bioink for dormancy) and resulted in different primary tumor growth (Matrigel significantly higher than Cellink Bioink). Light-sheet fluorescence microscopy revealed differences in vascularization and hemorrhages with no additional vessels found in Cellink Bioink. Histologically, typical human melanoma with different stages was demonstrated. HMB-45-positive tumors in progression inks were infiltrated by macrophages (CD163), highly proliferative (Ki67) and metastatic (MITF/BRN2, ATX, MMP3). Stainings of lymph nodes revealed metastases even without significant primary tumor growth in Cellink Bioink. This model can be used to study tumor pathology and metastasis of different tumor stages and therapies.

Citing Articles

Plasticity of Expression of Stem Cell and EMT Markers in Breast Cancer Cells in 2D and 3D Culture Depend on the Spatial Parameters of Cell Growth; Mathematical Modeling of Mechanical Stress in Cell Culture in Relation to ECM Stiffness.

Szostakowska-Rodzos M, Chmielarczyk M, Zacharska W, Fabisiewicz A, Kurzyk A, Mysliwy I Bioengineering (Basel). 2025; 12(2).

PMID: 40001667 PMC: 11852359. DOI: 10.3390/bioengineering12020147.


Characterization of two different alginate-based bioinks and the influence of melanoma growth within.

Schipka R, Heltmann-Meyer S, Schneidereit D, Friedrich O, Roder J, Boccaccini A Sci Rep. 2024; 14(1):12945.

PMID: 38839791 PMC: 11153560. DOI: 10.1038/s41598-024-63642-3.

References
1.
Boos A, Loew J, Weigand A, Deschler G, Klumpp D, Arkudas A . Engineering axially vascularized bone in the sheep arteriovenous-loop model. J Tissue Eng Regen Med. 2012; 7(8):654-64. DOI: 10.1002/term.1457. View

2.
Cho W, Ahn M, Kim B, Cho D . Blood-Lymphatic Integrated System with Heterogeneous Melanoma Spheroids via In-Bath Three-Dimensional Bioprinting for Modelling of Combinational Targeted Therapy. Adv Sci (Weinh). 2022; 9(29):e2202093. PMC: 9561777. DOI: 10.1002/advs.202202093. View

3.
Schulik J, Salehi S, Boccaccini A, Schrufer S, Schubert D, Arkudas A . Comparison of the Behavior of 3D-Printed Endothelial Cells in Different Bioinks. Bioengineering (Basel). 2023; 10(7). PMC: 10376299. DOI: 10.3390/bioengineering10070751. View

4.
Zhuang P, Chiang Y, Fernanda M, He M . Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment. Int J Bioprint. 2021; 7(4):444. PMC: 8600307. DOI: 10.18063/ijb.v7i4.444. View

5.
Arkudas A, Pryymachuk G, Hoereth T, Beier J, Polykandriotis E, Bleiziffer O . Dose-finding study of fibrin gel-immobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat model. Tissue Eng Part A. 2009; 15(9):2501-11. DOI: 10.1089/ten.tea.2008.0477. View